Department of Experimental Animal Facilities and Biorisk Management
For the detection of diagnostically relevant viruses, a series of monoclonal antibodies (mAb) has been developed. The emphasis has been laid on pathogens for which antibodies are not commercially available or available quantities are insufficient. Some of the developed mAbs can be supplied in small amounts to diagnostic and research laboratories. Contracts on the commercial use of mAbs on the basis of licence agreements are also possible.